CDER Announces New Center For Clinical Trial Innovation

FDA’s Center for Drug Evaluation and Research (CDER) is launching a new center that will focus on promoting innovative clinical trial approaches through internal and external collaboration, to be known as the Center for Clinical Trial Innovation (C3TI). The center will kick off with projects on point-of-care or pragmatic trials, Bayesian analyses, and trials using selective safety data collection. The center was announced in a Federal Register notice Monday (April 15). “CDER’s long-standing efforts to embed innovation in clinical...